Inogen Inc
INGN6.750USD
+0.040+0.60%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
183.25MMarket Cap
LossP/E TTM
More Details of Inogen Inc Company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Inogen Inc Info
Ticker SymbolINGN
Company nameInogen Inc
IPO dateFeb 14, 2014
CEOSmith (Kevin R. M)
Number of employees766
Security typeOrdinary Share
Fiscal year-endFeb 14
Address859 Ward Drive
CityGOLETA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code93111
Phone18055620500
Websitehttps://www.inogen.com/
Ticker SymbolINGN
IPO dateFeb 14, 2014
CEOSmith (Kevin R. M)
Company Executives of Inogen Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
U.S. revenue
56.35M
61.07%
Non-U.S. revenue
35.92M
38.93%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
Other
72.04%
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
Other
72.04%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.98%
Investment Advisor/Hedge Fund
25.85%
Hedge Fund
18.26%
Corporation
9.67%
Individual Investor
2.48%
Research Firm
1.98%
Family Office
0.89%
Pension Fund
0.27%
Bank and Trust
0.20%
Other
14.42%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.71%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
5.61%
-63.70K
-4.03%
Jun 30, 2025
The Vanguard Group, Inc.
1.65M
6.12%
+113.18K
+7.35%
Jun 30, 2025
Acadian Asset Management LLC
1.02M
3.76%
-11.08K
-1.08%
Jun 30, 2025
Camber Capital Management LP
975.00K
3.61%
--
--
Jun 30, 2025
Armistice Capital LLC
664.00K
2.46%
+664.00K
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
881.10K
3.26%
+6.57K
+0.75%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
832.19K
3.08%
+75.07K
+9.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
615.28K
2.28%
+44.86K
+7.86%
Jun 30, 2025
Dafna Capital Management, LLC
605.63K
2.24%
+147.56K
+32.21%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
View more
Cultivar ETF
Proportion0.59%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.55%
Federated Hermes MDT Small Cap Core ETF
Proportion0.25%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.11%
iShares Micro-Cap ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Inogen Inc?
The top five shareholders of Inogen Inc are:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP holds 2.63M shares, accounting for 9.71% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.52M shares, accounting for 5.61% of the total shares.
The Vanguard Group, Inc. holds 1.65M shares, accounting for 6.12% of the total shares.
Acadian Asset Management LLC holds 1.02M shares, accounting for 3.76% of the total shares.
Camber Capital Management LP holds 975.00K shares, accounting for 3.61% of the total shares.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP holds 2.63M shares, accounting for 9.71% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.52M shares, accounting for 5.61% of the total shares.
The Vanguard Group, Inc. holds 1.65M shares, accounting for 6.12% of the total shares.
Acadian Asset Management LLC holds 1.02M shares, accounting for 3.76% of the total shares.
Camber Capital Management LP holds 975.00K shares, accounting for 3.61% of the total shares.
What are the top three shareholder types of Inogen Inc?
The top three shareholder types of Inogen Inc are:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of Inogen Inc (INGN)?
As of 2025Q3, 308 institutions hold shares of Inogen Inc, with a combined market value of approximately 19.98M, accounting for 73.65% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -11.03%.
What is the biggest source of revenue for Inogen Inc?
In FY2025Q2, the -- business generated the highest revenue for Inogen Inc, amounting to -- and accounting for --% of total revenue.
